Reimbursement News Reimbursement news and insurance coverage updates. CMS Repeals Rule Aimed at Expediting Medicare Coverage for FDA Breakthrough Devices The rule would have granted quicker Medicare coverage for up to four years for tests that had received breakthrough device designation from the FDA. Palmetto Finalizes Medicare Coverage for MRD Cancer Testing To receive coverage, the patient must have a personal history of cancer where the type and staging are within the intended use of the test. Adaptive Biotechnologies' T-Cell Assay Plans Boosted by Medicare Nod for COVID Test Premium The company has slightly extended its timeline for launching a Lyme disease test to focus on marketing its COVID assay for immunocompromised individuals. Labs Ask Medicare Contractor to Refine Coverage Policy for 'Comprehensive' NGS Cancer Testing Premium National Government Services' proposal to broaden coverage of large sequencing panels for solid tumor patients is positive but may need clarification to ensure appropriate patient care. California Bill Prohibiting Prior Authorizations for Cancer Biomarker Testing Becomes Law The law will restrict insurers from requiring doctors to get coverage approval before ordering biomarker testing for advanced cancer patients. Jul 6, 2021 Concert Genetics New Test ID Tool Works to Improve Reimbursement Process Premium Jun 23, 2021 Genomic Testing Cooperative's Hematologic Neoplasms, Solid Tumor Tests Receive NY State Approval, Medicare Coverage Jun 4, 2021 Veracyte Bladder Cancer Test Receives Medicare Coverage May 28, 2021 Roche, Canadian Organizations Launch Real-World Evidence Framework in British Columbia May 28, 2021 Postponed CMS Proposal Would Remove Unspecified Cancer Dx Codes, Impacting Test Access Premium May 21, 2021 Palmetto Releases Draft LCD for Prostate Cancer Risk Stratification Tests May 10, 2021 Medicare Expands Coverage for Hologic's Biotheranostics Breast Cancer Test Apr 22, 2021 Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection Mar 16, 2021 New AMP Survey Reports Insufficient Reimbursement for Analysis, Interpretation of MDx Test Results Jan 26, 2021 Genomind Receives Medicare Coverage for Pharmacogenetics Test Jan 20, 2021 CMS Finalizes Blood-Based Colon Cancer Screening NCD with Non-Coverage for Epi ProColon Dec 8, 2020 Illumina, Harvard Pilgrim Health Care Ink Risk-Sharing Deal for Whole-Genome Sequencing Dec 3, 2020 Aetna Updates Noninvasive Prenatal Testing Coverage Policy to Include All Pregnancies Dec 3, 2020 Local Coverage Determinations Roundup: Castle Bio Dec 2, 2020 Diaceutics, Alva10 Gathering Evidence Base for Improving PD-L1 Test Reimbursement Premium Dec 1, 2020 UnitedHealthcare to Cover NIPT for Average-Risk Pregnancies Nov 19, 2020 CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests Nov 13, 2020 Clinical Genomics Nabs Medicare Coverage for Colorectal Cancer Test as Novitas Revises LCD Nov 6, 2020 Medicare Administrative Contractor CGS Aligns Coverage for Melanoma Risk Stratification Tests Oct 29, 2020 Humana Broadens Coverage of NIPT for Average Risk Pregnancies Load More Breaking News GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy Metabolomic Study Links 13 Metabolites to Coronary Heart Disease Risk Among African Americans Illumina Wins $8M Jury Verdict in BGI Patent Infringement Suit, Loses Patent Caris Life Sciences Facing FTC Lawsuit After Resisting Subpoena in Illumina, Grail Antitrust Case Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests The Scan Panel Votes for COVID-19 Pill A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says. But Not Harm New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare. Effectiveness Drop Anticipated Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports. Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.